Last update 28 Jul 2025

SYN608

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
PARG
Action
inhibitors
Mechanism
PARG inhibitors(Poly(ADP-ribose) glycohydrolase inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
BRCA mutation positive Breast CancerHRD positive cancerLocally Advanced Malignant Solid Neoplasm+ [2]
Inactive Indication-
Originator Organization
SynRx Therapeutics Co., Ltd.
Active Organization
SynRx Therapeutics Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SYN608
NCT07088588
/ Not yet recruitingPhase 1
A First-in-Human Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of SYN608, a Poly ADP-ribose Glycohydrolase (PARG) Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
100 Clinical Results associated with SYN608
Login to view more data
100 Translational Medicine associated with SYN608
Login to view more data
100 Patents (Medical) associated with SYN608
Login to view more data
100 Deals associated with SYN608
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
BRCA mutation positive Breast CancerPhase 1
China
SynRx Therapeutics Co., Ltd.
31 Jul 2025
HRD positive cancerPhase 1
China
SynRx Therapeutics Co., Ltd.
31 Jul 2025
Locally Advanced Malignant Solid NeoplasmPhase 1
China
SynRx Therapeutics Co., Ltd.
31 Jul 2025
Metastatic Solid TumorPhase 1
China
SynRx Therapeutics Co., Ltd.
31 Jul 2025
Ovarian CancerPhase 1
China
SynRx Therapeutics Co., Ltd.
31 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free